ArticlePloS one2017

Characterization of a Broadly Reactive Anti-CD40 Agonistic Monoclonal Antibody for Potential Use as an Adjuvant.

Cameron Martin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.